Overview
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 14, 2021 | Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases | Valerie Daggett, founder and CEO of AltPep. (UW Photo) AltPep, a Seattle-based biotech startup tackling amyloid protein disorders, has raised $23.1 million in a Series A funding round. The venture spun out the University of Washington in Ma... |
| May 23, 2020 | Healthcare giant Roche acquires Seattle DNA sequencing startup Stratos Genomics | Mark Kokoris, President, CEO, and co-founder at Stratos Genomics. (Stratos Photo) Publicly-traded pharmaceutical giant Roche acquired Stratos Genomics, a Seattle DNA sequencing startup. Founded in 2007, Stratos’ technology is called Sequenc... |
| Aug 11, 2019 | 3D-printing organs moves a few more steps closer to commercialization | New successes in printing vascular tissue from living cells point to the accelerating pace of development of 3D-printing tissue — and eventually the ability to manufacture organs from small samples of cells. Late last month Prellis Biologic... |
Reviews 0
FAQ about University of Washington Bioengineering
When was University of Washington Bioengineering founded?
University of Washington Bioengineering was founded in 1967.
What has the press written about University of Washington Bioengineering?
Parsers VC has collected 4 articles mentioning University of Washington Bioengineering, among them “Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases” (Jan 14, 2021) and “Healthcare giant Roche acquires Seattle DNA sequencing startup Stratos Genomics” (May 23, 2020).
Is University of Washington Bioengineering still active?
Yes, University of Washington Bioengineering is active; its latest activity on Parsers VC dates from Sep 29, 2022.